NeoGenomics, Inc. (NEO) vs GeneDx Holdings Corp. (WGS)
- NeoGenomics, Inc. NEO 16.65 −3.48%
- GeneDx Holdings Corp. WGS 63.60 −9.43%
NeoGenomics, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. NeoGenomics, Inc. and GeneDx Holdings Corp. are of similar size ($2.2B and $2.1B). GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 11.2%. NeoGenomics, Inc. has the higher net margin (−6.77% vs −23.4%) and the higher return on invested capital (−4.20% vs −27.7%). Across the 18 metrics below, NeoGenomics, Inc. leads on 12 and GeneDx Holdings Corp. on 6.
Valuation
Profitability
| Metric | NEO | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 43.92% | 69.37% | 50.89% |
| Operating margin | (8.93%) | (20.34%) | (8.57%) |
| Net margin | (6.77%) | (23.40%) | (6.37%) |
| Free cash flow margin | (0.69%) | (16.68%) | 0.00% |
| Return on equity | (6.33%) | (40.80%) | (2.92%) |
| Return on assets | (3.78%) | (22.50%) | (6.71%) |
| Return on invested capital | (4.20%) | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack